Parabolic Drugs Q1 profit rise by 36.29%
July 20, 2010
Parabolic Drugs Q2FY11 Net Profit up 163.65% at Rs. 14.29 crore, Sales up 16.23% at Rs. 161.43 crore
November 8, 2010
Parabolic Drugs Q1 profit rise by 36.29%
July 20, 2010
Parabolic Drugs Q2FY11 Net Profit up 163.65% at Rs. 14.29 crore, Sales up 16.23% at Rs. 161.43 crore
November 8, 2010

ISO 14001 certification for PDL

 

ISO 14001 certification for PDL

The Company's Derabassi manufacturing Site has been accredited with the ISO 14001:2004 certificate for meeting the Environmental Management System Standards.

This 27 acre facility, a dedicated Cephalosporin API & intermediate manufacturing site, was audited by DNV (Det Norske Veritas) certification agency from Netherlands and found to be compliant with the highest standards of Environmental management systems.

The certification validates that all the activities on this plant related to manufacturing of API and Drug Intermediates conform to international standards of Environmental protection and that there are no harmful effluents released in the environment by the Company.

The Company has efficient waste management systems and green belts in order to avoid the impact of chemical processes taking place in the Plant on its surroundings. The certification is valid till August 2012 and will be revisited thereafter.

Leave a Reply

Your email address will not be published. Required fields are marked *

18 + 16 =